Yıl: 2022 Cilt: 28 Sayı: 5 Sayfa Aralığı: 403 - 409 Metin Dili: İngilizce DOI: 10.5152/dir.2022.201112 İndeks Tarihi: 09-11-2022

Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer

Öz:
PURPOSE This study aimed to retrospectively evaluate the apparent diffusion coefficient (ADC) histograms in predicting chemoradiotherapy (CRT) response in patients with locally advanced rectal cancer (LARC). METHODS A total of 51 patients who underwent surgery in our institution for rectal cancer following neo adjuvant CRT between November 2013 and July 2019 were enrolled. Conventional magnetic resonance (MR) and diffusion-weighted images obtained before and after CRT were evaluated retrospectively. All tumor-containing regions of interests were drawn in 3 selected axial images, and special software for histogram analysis was used to evaluate ADC distribution. ADC cutoff values from post-CRT ADC histogram were calculated from receiver operating characteristic (ROC) analysis for evaluating CRT response. RESULTS In histopathological analysis, 5 patients (9.8%) had minimal response (group 1), 31 patients (60.8%) had partial response (group 2), and 15 patients (29.4%) had complete or almost com plete response (group 3). In the ADC histogram, minimum, maximum, 10th, 25th, 50th, 75th, and 90th percentile, mean ADC values, and skewness values of groups 2 and 3 showed significant changes before and after CRT, but no difference was found within group 1 values. The mean, 25th, 50th, 75th percent ADC values after CRT and skewness, and kurtosis values were signifi cantly different between group 1 and group 3. Skewness value from the ADC histogram in post CRT magnetic resonance imaging had the best diagnostic performance with an area under the ROC curve of 0.851 (P =.003) for detecting group 3. The skewness cutoff calculated from the ROC analysis was 0.210 for evaluating CRT response. The sensitivity and specificity of the cut-off value were 100% and 61.4%, respectively. CONCLUSION The ADC histogram analysis seems to have potential application in predicting response to neo adjuvant CRT in patients with locally advanced rectal cancer.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30. [CrossRef]
  • 2. Sagar PM, Pemberton JH. Surgical manage ment of locally recurrent rectal cancer. Br J Surg. 1996;83(3):293-304. [CrossRef]
  • 3. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344(8924):707-711. [CrossRef]
  • 4. Rana N, Chakravarthy AB, Kachnic LA. Neoad juvant treatment for locally advanced rectal cancer: new concepts in clinical trial design. Curr Treat Options Oncol. 2017;18(2):13. [CrossRef]
  • 5. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffu sion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo and radiation therapy. Radiology. 2009;253(1):116-125. [CrossRef]
  • 6. Lambrecht M, Vandecaveye V, De Keyzer F, et al. Value of diffusion-weighted magnetic reso nance imaging for prediction and early assess ment of response to neoadjuvant radiochem otherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82(2):863-870. [CrossRef]
  • 7. Delli Pizzi A, Basilico R, Cianci R, et al. Rectal cancer MRI: protocols, signs and future per spectives radiologists should consider in eve ryday clinical practice. Insights Imaging. 2018;9(4):405-412. [CrossRef]
  • 8. Haak HE, Maas M, Lahaye MJ, et al. Selection of patients for organ preservation after chemora diotherapy: MRI identifies poor responders who can go straight to surgery. Ann Surg Oncol. 2020;27(8):2732-2739. [CrossRef]
  • 9. Lambregts DMJ, Maas M, Boellaard TN, et al. Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer—an evaluation of over 1500 MRIs. Eur Radiol. 2020;30(1):272-280. [CrossRef]
  • 10. Pham TT, Liney GP, Wong K, Barton MB. Func tional MRI for quantitative treatment response prediction in locally advanced rectal cancer. Br J Radiol. 2017;90(1072):20151078. [CrossRef]
  • 11. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18(8):2224-2231. [CrossRef]
  • 12. Nerad E, Delli Pizzi A, Lambregts DMJ, et al. The apparent diffusion coefficient (ADC) is a useful biomarker in predicting metastatic colon can cer using the ADC-value of the primary tumor. PLoS ONE. 2019;14(2):e0211830. [CrossRef]
  • 13. Chidambaram V, Brierley JD, Cummings B, et al. Investigation of volumetric apparent diffu sion coefficient histogram analysis for assess ing complete response and clinical outcomes following pre-operative chemoradiation treat ment for rectal carcinoma. Abdom Radiol (NY). 2017;42(5):1310-1318. [CrossRef]
  • 14. Choi MH, Oh SN, Rha SE, et al. Diffusion weighted imaging: apparent diffusion coeffi cient histogram analysis for detecting patho logic complete response to chemoradiother apy in locally advanced rectal cancer. J Magn Reson Imaging. 2016;44(1):212-220. [CrossRef]
  • 15. Delli Pizzi A, Cianci R, Genovesi D, et al. Perfor mance of diffusion-weighted magnetic reso nance imaging at 3.0T for early assessment of tumor response in locally advanced rectal can cer treated with preoperative chemoradiation therapy. Abdom Radiol (NY). 2018;43(9):2221- 2230. [CrossRef]
  • 16. Nasu K, Kuroki Y, Minami M. Diffusion-weighted imaging findings of mucinous carcinoma aris ing in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma. Jpn J Radiol. 2012;30(2):120-127. [CrossRef]
  • 17. Dworak O, Keilholz L, Hoffmann A. Pathologi cal features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19-23. [CrossRef]
  • 18. Roh MS, Colangelo LH, O'Connell MJ, et al. Pre operative multimodality therapy improves disease-free survival in patients with carci noma of the rectum: NSABP R-03. J Clin Oncol. 2009;27(31):5124-5130. [CrossRef]
  • 19. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29(35):4633-4640. [CrossRef]
  • 20. Renehan AG, Malcomson L, Emsley R, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016;17(2):174-183. [CrossRef]
  • 21. Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer: MR imaging in predic tion of response after preoperative chemo therapy and radiation therapy. Radiology. 2009;250(3):730-739. [CrossRef]
  • 22. Wu LM, Zhu J, Hu J, et al. Is there a benefit in using magnetic resonance imaging in the pre diction of preoperative neoadjuvant therapy response in locally advanced rectal cancer? Int J Colorectal Dis. 2013;28(9):1225-1238. [CrossRef]
  • 23. Napoletano M, Mazzucca D, Prosperi E, et al. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy. Abdom Radiol (NY). 2019;44(11):3664-3673. [CrossRef]
  • 24. Lambregts DM, Beets GL, Maas M, et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol. 2011;21(12):2567-2574. [CrossRef]
  • 25. Monguzzi L, Ippolito D, Bernasconi DP, Trat tenero C, Galimberti S, Sironi S. Locally advanced rectal cancer: value of ADC map ping in prediction of tumor response to radio chemotherapy. Eur J Radiol. 2013;82(2): 234-240. [CrossRef]
  • 26. Enkhbaatar NE, Inoue S, Yamamuro H, et al. MR imaging with apparent diffusion coefficient histogram analysis: evaluation of locally advanced rectal cancer after chemotherapy and radiation therapy. Radiology. 2018;288(1):129-137. [CrossRef]
  • 27. Foti PV, Privitera G, Piana S, et al. Locally advanced rectal cancer: Qualitative and quan titative evaluation of diffusion-weighted MR imaging in the response assessment after neo adjuvant chemo-radiotherapy. Eur J Radiol Open. 2016;3:145-152. [CrossRef]
  • 28. Hein PA, Kremser C, Judmaier W, et al. Diffu sion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal car cinoma during combined, preoperative chem oradiation: preliminary results of a prospective study. Eur J Radiol. 2003;45(3):214-222. [CrossRef]
  • 29. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent dif fusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol. 2003;179(9):641-649. [CrossRef]
  • 30. Amodeo S, Rosman AS, Desiato V, et al. MRI based apparent diffusion coefficient for pre dicting pathologic response of rectal cancer after neoadjuvant therapy: systematic review and meta-analysis. AJR Am J Roentgenol. 2018;211(5):W205-W216. [CrossRef]
APA Babatürk A, Erden A, Gecim I (2022). Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. , 403 - 409. 10.5152/dir.2022.201112
Chicago Babatürk Andelib,Erden Ayşe,Gecim Ibrahim Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. (2022): 403 - 409. 10.5152/dir.2022.201112
MLA Babatürk Andelib,Erden Ayşe,Gecim Ibrahim Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. , 2022, ss.403 - 409. 10.5152/dir.2022.201112
AMA Babatürk A,Erden A,Gecim I Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. . 2022; 403 - 409. 10.5152/dir.2022.201112
Vancouver Babatürk A,Erden A,Gecim I Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. . 2022; 403 - 409. 10.5152/dir.2022.201112
IEEE Babatürk A,Erden A,Gecim I "Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer." , ss.403 - 409, 2022. 10.5152/dir.2022.201112
ISNAD Babatürk, Andelib vd. "Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer". (2022), 403-409. https://doi.org/10.5152/dir.2022.201112
APA Babatürk A, Erden A, Gecim I (2022). Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. Diagnostic and Interventional Radiology, 28(5), 403 - 409. 10.5152/dir.2022.201112
Chicago Babatürk Andelib,Erden Ayşe,Gecim Ibrahim Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. Diagnostic and Interventional Radiology 28, no.5 (2022): 403 - 409. 10.5152/dir.2022.201112
MLA Babatürk Andelib,Erden Ayşe,Gecim Ibrahim Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. Diagnostic and Interventional Radiology, vol.28, no.5, 2022, ss.403 - 409. 10.5152/dir.2022.201112
AMA Babatürk A,Erden A,Gecim I Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. Diagnostic and Interventional Radiology. 2022; 28(5): 403 - 409. 10.5152/dir.2022.201112
Vancouver Babatürk A,Erden A,Gecim I Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer. Diagnostic and Interventional Radiology. 2022; 28(5): 403 - 409. 10.5152/dir.2022.201112
IEEE Babatürk A,Erden A,Gecim I "Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer." Diagnostic and Interventional Radiology, 28, ss.403 - 409, 2022. 10.5152/dir.2022.201112
ISNAD Babatürk, Andelib vd. "Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer". Diagnostic and Interventional Radiology 28/5 (2022), 403-409. https://doi.org/10.5152/dir.2022.201112